Company intelligence / Profile preview

Vetochas

Ownership: Private
Development stage: Other

Overview

Vetochas is an early-stage biotechnology company focused on the development of novel therapeutic agents. The company's research primarily targets areas within infectious diseases and oncology, utilizing a combination of small molecule and peptide-based approaches. While currently in the pre-clinical phase, Vetochas aims to advance its pipeline through rigorous validation of its lead candidates. The company operates as a private entity, focusing on foundational R&D to address unmet medical needs.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Vetochas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vetochas.

Explore the full profile